Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1983 Mar;49(3):214–221. doi: 10.1136/hrt.49.3.214

Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate.

J Bayliss, M Norell, R Canepa-Anson, S R Reuben, P A Poole-Wilson, G C Sutton
PMCID: PMC481291  PMID: 6830658

Abstract

A randomised, within patient comparison was made in patients with severe chronic heart failure, to study the acute haemodynamic effects of oral agents which have inotropic and vasodilator properties. A non-glycosidic non-adrenergic positive inotropic agent with vasodilator properties (amrinone) was compared with a beta-agonist which has vasodilator and positive inotropic effects (pirbuterol). To assess whether combined treatment with a venodilator might be advantageous, the effect of adding isosorbide dinitrate was studied. Oral amrinone or pirbuterol were given in random order to each of 13 patients, on successive days, and oral isosorbide dinitrate was added after two-and-a-half hours. Control values before amrinone or pirbuterol were similar, and both drugs increased cardiac index while reducing left ventricular filling pressure, right atrial pressure, and systemic vascular resistance. Heart rate and blood pressure were unchanged. The magnitude of the changes caused by amrinone and pirbuterol were not significantly different. The addition of isosorbide dinitrate caused further falls in left ventricular filling pressure and right atrial pressures, and a fall in heart rate with each drug. Other measurements remained unchanged. Although amrinone and pirbuterol have different pharmacological properties, their acute haemodynamic effects in patients with chronic heart failure are indistinguishable.

Full text

PDF
214

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Awan N. A., Needham K. E., Evenson M. K., Mason D. T. Comparison of hemodynamic actions of pirbuterol and dobutamine on cardiac function in severe congestive heart failure. Am J Cardiol. 1981 Mar;47(3):665–669. doi: 10.1016/0002-9149(81)90552-x. [DOI] [PubMed] [Google Scholar]
  2. Benotti J. R., Grossman W., Braunwald E., Carabello B. A. Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease. Circulation. 1980 Jul;62(1):28–34. doi: 10.1161/01.cir.62.1.28. [DOI] [PubMed] [Google Scholar]
  3. Benotti J. R., Grossman W., Braunwald E., Davolos D. D., Alousi A. A. Hemodynamic assessment of amrinone. A new inotropic agent. N Engl J Med. 1978 Dec 21;299(25):1373–1377. doi: 10.1056/NEJM197812212992501. [DOI] [PubMed] [Google Scholar]
  4. Canepa-Anson R., Dawson J. R., Kuan P., Warnes C. A., Poole-Wilson P. A., Reuben S. R., Sutton G. C. Single-dose and dose-response studies with oral pirbuterol, a new beta agonist in chronic heart failure. Am Heart J. 1981 Sep;102(3 Pt 2):578–583. doi: 10.1016/0002-8703(81)90747-x. [DOI] [PubMed] [Google Scholar]
  5. Chatterjee K., Parmley W. W. Vasodilator treatment for acute and chronic heart failure. Br Heart J. 1977 Jul;39(7):706–720. doi: 10.1136/hrt.39.7.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cohn J. N., Franciosa J. A. Vasodilator therapy of cardiac failure: (first of two parts). N Engl J Med. 1977 Jul 7;297(1):27–31. doi: 10.1056/NEJM197707072970105. [DOI] [PubMed] [Google Scholar]
  7. Dawson J. R., Canepa-Anson R., Kuan P., Whitaker N. H., Carnie J., Warnes C., Reuben S. R., Poole-Wilson P. A., Sutton G. C. Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses. Br Med J (Clin Res Ed) 1981 May 2;282(6274):1423–1426. doi: 10.1136/bmj.282.6274.1423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Edelson J., LeJemtel T. H., Alousi A. A., Biddlecome C. E., Maskin C. S., Sonnenblick E. H. Relationship between amrinone plasma concentration and cardiac index. Clin Pharmacol Ther. 1981 Jun;29(6):723–728. doi: 10.1038/clpt.1981.102. [DOI] [PubMed] [Google Scholar]
  9. Kullberg M. P., Dorrbecker B., Lennon J., Rowe E., Edelson J. High-performance liquid chromatographic analysis of amrinone and its N-acetyl derivative in plasma. Pharmacokinetics of amrinone in the dog. J Chromatogr. 1980 Jan 4;187(1):264–270. doi: 10.1016/s0021-9673(00)87899-1. [DOI] [PubMed] [Google Scholar]
  10. LeJemtel T. H., Keung E. C., Schwartz W. J., Maskin C. S., Greenberg M. A., Davis R. S., Forman R., Ribner H. S., Sonnenblick E. H. Hemodynamic effects of intravenous and oral amrinone in patients with severe heart failure: relationship between intravenous and oral administration. Trans Assoc Am Physicians. 1979;92:325–333. [PubMed] [Google Scholar]
  11. LeJemtel T. H., Keung E., Ribner H. S., Davis R., Wexler J., Blaufox J. D., Sonnenblick E. H. Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure. Am J Cardiol. 1980 Jan;45(1):123–129. doi: 10.1016/0002-9149(80)90229-5. [DOI] [PubMed] [Google Scholar]
  12. LeJemtel T. H., Keung E., Sonnenblick E. H., Ribner H. S., Matsumoto M., Davis R., Schwartz W., Alousi A. A., Davolos D. Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man. Circulation. 1979 Jun;59(6):1098–1104. doi: 10.1161/01.cir.59.6.1098. [DOI] [PubMed] [Google Scholar]
  13. Mason D. T. Usefulness and limitations of the rate of rise of intraventricular pressure (dp-dt) in the evaluation of myocardial contractility in man. Am J Cardiol. 1969 Apr;23(4):516–527. doi: 10.1016/0002-9149(69)90005-8. [DOI] [PubMed] [Google Scholar]
  14. Mikulic E., Cohn J. N., Franciosa J. A. Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure. Circulation. 1977 Oct;56(4 Pt 1):528–533. doi: 10.1161/01.cir.56.4.528. [DOI] [PubMed] [Google Scholar]
  15. Miller R. R., Awan N. A., DeMaria A. N., Amsterdam E. A., Mason D. T. Importance of maintaining systemic blood pressure during nitroglycerin administration for reducing ischemic injury in patients with coronary disease. Effects on coronary blood flow, myocardial energetics and left ventricular function. Am J Cardiol. 1977 Oct;40(4):504–508. doi: 10.1016/0002-9149(77)90063-7. [DOI] [PubMed] [Google Scholar]
  16. Miller R. R., Palomo A. R., Brandon T. A., Hartley C. J., Quinones M. A. Combined vasodilator and inotropic therapy of heart failure: experimental and clinical concepts. Am Heart J. 1981 Sep;102(3 Pt 2):500–508. doi: 10.1016/0002-8703(81)90738-9. [DOI] [PubMed] [Google Scholar]
  17. Miller R. R., Vismara L. A., Williams D. O., Amsterdam E. A., Mason D. T. Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation. Circ Res. 1976 Jul;39(1):127–133. doi: 10.1161/01.res.39.1.127. [DOI] [PubMed] [Google Scholar]
  18. Mueller H. S., Evans R., Ayres S. M. Effect of dopamine on hemodynamics and myocardial metabolism in shock following acute myocardial infarction in man. Circulation. 1978 Feb;57(2):361–365. doi: 10.1161/01.cir.57.2.361. [DOI] [PubMed] [Google Scholar]
  19. Mueller H., Ayres S. M., Giannelli S., Jr, Conklin E. F., Mazzara J. T., Grace W. J. Effect of isoproterenol,l-norepinephrine, and intraaortic counterpulsation on hemodynamics and myocardial metabolism in shock following acute myocardial infarction. Circulation. 1972 Feb;45(2):335–351. doi: 10.1161/01.cir.45.2.335. [DOI] [PubMed] [Google Scholar]
  20. Rubin S. A., Lee S., O'Connor L., Hubenette A., Tober J., Swan H. J. Thrombocytopenia and fever in a patient taking amrinone. N Engl J Med. 1979 Nov 22;301(21):1185–1185. doi: 10.1056/NEJM197911223012118. [DOI] [PubMed] [Google Scholar]
  21. Rude R. E., Grossman W., Colucci W. S., Benotti J. R., Carabello B. A., Wynne J., Malacoff R., Braunwald E. Problems in assessment of new pharmacologic agents for the heart failure patient. Am Heart J. 1981 Sep;102(3 Pt 2):584–590. doi: 10.1016/0002-8703(81)90748-1. [DOI] [PubMed] [Google Scholar]
  22. Rude R. E., Turi Z., Brown E. J., Lorell B. H., Colucci W. S., Mudge G. H., Jr, Taylor C. R., Grossman W. Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure. Circulation. 1981 Jul;64(1):139–145. doi: 10.1161/01.cir.64.1.139. [DOI] [PubMed] [Google Scholar]
  23. Siegel L. A., Keung E., Siskind S. J., Forman R., Feinberg H., Strom J., Efstathakis D., Sonnenblick E. H., LeJemtel T. H. Beneficial effects of amrinone-hydralazine combination on resting hemodynamics and exercise capacity in patients with severe congestive heart failure. Circulation. 1981 Apr;63(4):838–844. doi: 10.1161/01.cir.63.4.838. [DOI] [PubMed] [Google Scholar]
  24. Siskind S. J., Sonnenblick E. H., Forman R., Scheuer J., LeJemtel T. H. Acute substantial benefit of inotropic therapy with amrinone on exercise hemodynamics and metabolism in severe congestive heart failure. Circulation. 1981 Nov;64(5):966–973. doi: 10.1161/01.cir.64.5.966. [DOI] [PubMed] [Google Scholar]
  25. Taylor C. R., Baird J. R., Blackburn K. J., Cambridge D., Constantine J. W., Ghaly M. S., Hayden M. L., McIlhenny H. M., Moore P. F., Olukotun A. Y. Comparative pharmacology and clinical efficacy of newer agents in treatment of heart failure. Am Heart J. 1981 Sep;102(3 Pt 2):515–532. doi: 10.1016/0002-8703(81)90740-7. [DOI] [PubMed] [Google Scholar]
  26. Weber K. T., Andrews V., Janicki J. S., Wilson J. R., Fishman A. P. Amrinone and exercise performance in patients with chronic heart failure. Am J Cardiol. 1981 Jul;48(1):164–169. doi: 10.1016/0002-9149(81)90586-5. [DOI] [PubMed] [Google Scholar]
  27. Wynne J., Malacoff R. F., Benotti J. R., Curfman G. D., Grossman W., Holman B. L., Smith T. W., Braunwald E. Oral amrinone in refractory congestive heart failure. Am J Cardiol. 1980 Jun;45(6):1245–1249. doi: 10.1016/0002-9149(80)90485-3. [DOI] [PubMed] [Google Scholar]
  28. Zelis R., Flaim S. F., Moskowitz R. M., Nellis S. H. How much can we expect from vasodilator therapy in congestive heart failure? Circulation. 1979 Jun;59(6):1092–1097. doi: 10.1161/01.cir.59.6.1092. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES